JPH0331257A - Production of indole derivative - Google Patents
Production of indole derivativeInfo
- Publication number
- JPH0331257A JPH0331257A JP16576489A JP16576489A JPH0331257A JP H0331257 A JPH0331257 A JP H0331257A JP 16576489 A JP16576489 A JP 16576489A JP 16576489 A JP16576489 A JP 16576489A JP H0331257 A JPH0331257 A JP H0331257A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- group
- formulas
- hydrogen atom
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 20
- 150000002475 indoles Chemical class 0.000 title abstract description 7
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000005804 alkylation reaction Methods 0.000 claims abstract description 8
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 230000029936 alkylation Effects 0.000 claims abstract description 7
- LPAGFVYQRIESJQ-UHFFFAOYSA-N indoline Chemical class C1=CC=C2NCCC2=C1 LPAGFVYQRIESJQ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 5
- 230000001590 oxidative effect Effects 0.000 claims abstract description 5
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 4
- 230000003647 oxidation Effects 0.000 claims abstract description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 17
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- QWMFKVNJIYNWII-UHFFFAOYSA-N 5-bromo-2-(2,5-dimethylpyrrol-1-yl)pyridine Chemical compound CC1=CC=C(C)N1C1=CC=C(Br)C=N1 QWMFKVNJIYNWII-UHFFFAOYSA-N 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 abstract description 16
- 239000003814 drug Substances 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 5
- 230000002152 alkylating effect Effects 0.000 abstract description 4
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical group IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 abstract 1
- 238000005580 one pot reaction Methods 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 52
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 26
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000000243 solution Substances 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- -1 alkenyl halides Chemical class 0.000 description 10
- 239000000741 silica gel Substances 0.000 description 10
- 229910002027 silica gel Inorganic materials 0.000 description 10
- 238000012746 preparative thin layer chromatography Methods 0.000 description 9
- GTVWPXDPNQJYNV-UHFFFAOYSA-N 1-methoxyindole Chemical group C1=CC=C2N(OC)C=CC2=C1 GTVWPXDPNQJYNV-UHFFFAOYSA-N 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000000921 elemental analysis Methods 0.000 description 6
- 239000012046 mixed solvent Substances 0.000 description 6
- PTXVSDKCUJCCLC-UHFFFAOYSA-N 1-hydroxyindole Chemical class C1=CC=C2N(O)C=CC2=C1 PTXVSDKCUJCCLC-UHFFFAOYSA-N 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- 229940100198 alkylating agent Drugs 0.000 description 4
- 239000002168 alkylating agent Substances 0.000 description 4
- 230000005587 bubbling Effects 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 229910044991 metal oxide Inorganic materials 0.000 description 4
- 150000004706 metal oxides Chemical class 0.000 description 4
- 239000007800 oxidant agent Substances 0.000 description 4
- ZHQNIQVOVQMVNI-UHFFFAOYSA-N 1-methoxy-2-phenylindole Chemical compound C=1C2=CC=CC=C2N(OC)C=1C1=CC=CC=C1 ZHQNIQVOVQMVNI-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- CMPGARWFYBADJI-UHFFFAOYSA-L tungstic acid Chemical class O[W](O)(=O)=O CMPGARWFYBADJI-UHFFFAOYSA-L 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940054051 antipsychotic indole derivative Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 150000004972 metal peroxides Chemical class 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- GSCZNYAHWDLULJ-UHFFFAOYSA-N 1-hydroxy-2-phenylindole Chemical compound C=1C2=CC=CC=C2N(O)C=1C1=CC=CC=C1 GSCZNYAHWDLULJ-UHFFFAOYSA-N 0.000 description 1
- ORCCQYAOCNVXAR-UHFFFAOYSA-N 1-methoxy-6-nitroindole Chemical compound C1=C([N+]([O-])=O)C=C2N(OC)C=CC2=C1 ORCCQYAOCNVXAR-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- DPJCXCZTLWNFOH-UHFFFAOYSA-N 2-nitroaniline Chemical compound NC1=CC=CC=C1[N+]([O-])=O DPJCXCZTLWNFOH-UHFFFAOYSA-N 0.000 description 1
- PLAZTCDQAHEYBI-UHFFFAOYSA-N 2-nitrotoluene Chemical compound CC1=CC=CC=C1[N+]([O-])=O PLAZTCDQAHEYBI-UHFFFAOYSA-N 0.000 description 1
- LESSAHXSEYCBQF-UHFFFAOYSA-N 9-methoxycarbazole Chemical compound C1=CC=C2N(OC)C3=CC=CC=C3C2=C1 LESSAHXSEYCBQF-UHFFFAOYSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 101000619542 Homo sapiens E3 ubiquitin-protein ligase parkin Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- HHLNXXASUKFCCX-UHFFFAOYSA-N Neoxaline Natural products O=C1NC23N(OC)C4=CC=CC=C4C3(C(C)(C)C=C)CC(O)C(=O)N2C1=CC1=CN=CN1 HHLNXXASUKFCCX-UHFFFAOYSA-N 0.000 description 1
- 241001482576 Saiga Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- PBYACEFUBBWBPV-UHFFFAOYSA-N [O-][N+](=O)C1=CC=C2N(OC)C=CC2=C1 Chemical compound [O-][N+](=O)C1=CC=C2N(OC)C=CC2=C1 PBYACEFUBBWBPV-UHFFFAOYSA-N 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- SPWVRYZQLGQKGK-UHFFFAOYSA-N dichloromethane;hexane Chemical compound ClCCl.CCCCCC SPWVRYZQLGQKGK-UHFFFAOYSA-N 0.000 description 1
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 150000002483 hydrogen compounds Chemical group 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- VLAPMBHFAWRUQP-UHFFFAOYSA-L molybdic acid Chemical class O[Mo](O)(=O)=O VLAPMBHFAWRUQP-UHFFFAOYSA-L 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- HHLNXXASUKFCCX-LICLKQGHSA-N neoxaline Chemical compound O=C1NC23N(OC)C4=CC=CC=C4C3(C(C)(C)C=C)CC(O)C(=O)N2\C1=C\C1=CN=CN1 HHLNXXASUKFCCX-LICLKQGHSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 102000045222 parkin Human genes 0.000 description 1
- 150000004968 peroxymonosulfuric acids Chemical class 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- XMVONEAAOPAGAO-UHFFFAOYSA-N sodium tungstate Chemical compound [Na+].[Na+].[O-][W]([O-])(=O)=O XMVONEAAOPAGAO-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 150000004684 trihydrates Chemical class 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- LSGOVYNHVSXFFJ-UHFFFAOYSA-N vanadate(3-) Chemical class [O-][V]([O-])([O-])=O LSGOVYNHVSXFFJ-UHFFFAOYSA-N 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Indole Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明はインドール誘導体の製造方法に関するものであ
る。DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to a method for producing indole derivatives.
さらに詳しく述べれば、本発明は医薬品、動物用薬品、
農業用薬品あるいはそれらの製造中間体として有用な、
−数式
(式中のR1は水素原子、R2は水素原子、低級アルキ
ル基、カルボキシル基、低級アルコキシカルボニル基ま
たはフェニル基であるか、あるいはR1とR2が互いに
結合して−(CH2)じまたは−C)I=CH−CH=
CH−基を形成するものであり R3は水素原子、ハロ
ゲン原子またはニトロ基であり R4は水素原子、低級
アルキル基または低級アルケニル基である)で表される
インドール誘導体の効率的な製造方法に関するものであ
る。More specifically, the present invention relates to pharmaceuticals, veterinary drugs,
Useful as agricultural chemicals or their manufacturing intermediates,
- Numerical formula (in the formula, R1 is a hydrogen atom, R2 is a hydrogen atom, a lower alkyl group, a carboxyl group, a lower alkoxycarbonyl group, or a phenyl group, or R1 and R2 are bonded to each other and -(CH2) is the same or - C) I=CH-CH=
This invention relates to an efficient method for producing an indole derivative, which forms a CH- group, R3 is a hydrogen atom, a halogen atom, or a nitro group, and R4 is a hydrogen atom, a lower alkyl group, or a lower alkenyl group. It is.
従来の技術
インドール誘導体は種々の薬理作用を有しており、医薬
品等として有用な化合物も数多く知られている。BACKGROUND OF THE INVENTION Indole derivatives have various pharmacological effects, and many compounds useful as pharmaceuticals are known.
また、N−ヒドロキシインドール誘導体およびNアルコ
キシインドール誘導体の中にもN−メトキシインドール
骨格を有するアルカロイド類を始めとして薬理作用を示
す化合物が種々見出されており、医薬品等への応用が検
討されている。Furthermore, among N-hydroxyindole derivatives and N-alkoxyindole derivatives, various compounds have been found that exhibit pharmacological effects, including alkaloids having an N-methoxyindole skeleton, and their application to pharmaceuticals, etc. is being considered. There is.
例えば、天然物のネオキサリン(Neoxaline)
が中枢神経刺激作用を有すること〔ケミカル アンド
ファー7シユーテイカル ブレチン(Chem。For example, the natural product Neoxaline
has a central nervous system stimulating effect [Chemical and
Far 7 Schematic Bulletin (Chem.
Pharm、 Bull、> 28巻、2987ページ
、1980年〕、あるいは3−シアノメチル−1−メト
キンインドールが植物生長促進作用を示すこと〔アグリ
カルチャーアンド バイオロジカル ケミストリー(八
gr。Pharm.
Biol、 Chem、) 34巻、1590ヘージ、
1970年〕などが知られている。Biol, Chem,) Volume 34, 1590 Hage,
1970] are known.
これまで、N−メトキシインドール誘導体の製造方法と
して2−ニトロアニリンを出発原料として6エ程、通算
収率的20〜50%でN−メトキシインドールを得る方
法が知られている〔ジャーナル オブケミカル ソサイ
アティー パーキントランスアクションI (J、C
hem、 Soc、、 Perkin I)、1978
年、1117ページ〕。Until now, a method for producing N-methoxyindole derivatives using 2-nitroaniline as a starting material is known, in which N-methoxyindole is obtained in 6 steps with a total yield of 20-50% [Journal of Chemical Society Parkin transaction I (J,C
hem, Soc, Perkin I), 1978
year, 1117 pages].
しかしながら、この方法は工程数が多(操作も煩雑で、
再現性も悪いものであった。However, this method requires a large number of steps (the operations are complicated,
Reproducibility was also poor.
発明が解決しようとする課題
N−ヒドロキシインドール誘導体ふよびN−アルコキシ
インドール誘導体はその薬理作用から医薬品等への応用
が期待されるが、その合成の困烈さのためにあまり研究
が行われていない。Problems to be Solved by the Invention Although N-hydroxyindole derivatives and N-alkoxyindole derivatives are expected to be applied to pharmaceuticals due to their pharmacological effects, not much research has been conducted due to the difficulty of their synthesis. do not have.
本発明の目的は医薬品等あるいはそれらの製造中間体と
して有用な前記−数式(1)で表されるN−ヒドロキシ
インドール誘導体およびN−アルコキシインドール誘導
体の効率的な製造方法を提供することである。An object of the present invention is to provide an efficient method for producing N-hydroxyindole derivatives and N-alkoxyindole derivatives represented by formula (1) above, which are useful as pharmaceuticals or intermediates for their production.
課題を解決するための手段
本発明者らは容易で効率的なN−ヒドロキシインドール
誘導体およびN−アルコキシインドール誘導体の製造方
法を見出すべく研究を行った結果、先に2−二トロトル
エンを出発原料として用いることにより3工程、通算収
率的60%でN−メトキシインドールを製造する方法を
見出し発表した〔ペテロサイクシス(Heterocy
cles)、16巻、1523ページ、1981年;
ケミカル アンド ファー7シユーテイカル ブレチン
(Chem、 Pharm Bull、)、34巻、
677ページ、1986年〕。Means for Solving the Problems The present inventors conducted research to find an easy and efficient method for producing N-hydroxyindole derivatives and N-alkoxyindole derivatives, and found that 2-nitrotoluene was first used as a starting material. discovered and announced a method for producing N-methoxyindole in 3 steps with a total yield of 60% by using
cles), vol. 16, p. 1523, 1981;
Chemical and Fur 7 Schematic Bulletin (Chem, Pharm Bull), Volume 34,
677 pages, 1986].
しかしながら、この方法も工程数および操作等の面にお
いてなお満足のいくものではなかった。However, this method was still unsatisfactory in terms of the number of steps and operations.
本発明者らはさらに簡便なN−ヒドロキシインド−ル誘
導体およびN−アルコキシインドール誘導体の合成法を
見出すべく鋭意研究を続けた結果、2゜3−ジヒドロイ
ンドール誘導体を出発原料として用い、これを適当な酸
化剤を用いて酸化した後、必要に応じてアルキル化剤で
アルキル化することにより容易にしかもlボットで目的
物が製造できることを見出し、本発明をなすに至った。The present inventors continued intensive research to find a simpler method for synthesizing N-hydroxyindole derivatives and N-alkoxyindole derivatives, and as a result, they used a 2゜3-dihydroindole derivative as a starting material and synthesized it in an appropriate manner. The inventors have discovered that the desired product can be produced easily and in one batch by oxidizing with a suitable oxidizing agent and then alkylating with an alkylating agent if necessary, and have accomplished the present invention.
すなわち、本発明は、−数式
(式中の1111.R2およびR3は前記と同じ意味を
もつ)で表される2、3−ジヒドロインドール誘導体を
酸化した後、必要に応じてアルキル化することを特徴と
する、−数式
(式中のR’、R2、R3およびR4は前記と同じ意味
をもつ)で表されるインドール誘導体の製造方法を提供
するものである。That is, the present invention provides for oxidizing a 2,3-dihydroindole derivative represented by the formula (1111.R2 and R3 have the same meanings as above) and then alkylating it as necessary. The present invention provides a method for producing an indole derivative represented by the formula (in which R', R2, R3, and R4 have the same meanings as described above).
本発明の製造方法で得られる前記−数式(1)の化合物
中、R1、R2、R3が水素原子、R4がメチル基であ
る化合物およびR1,R3が水素原子、R2がフェニル
基、R4が水素原子またはメトキシ基である化合物以外
は新規である。Among the compounds of formula (1) obtained by the production method of the present invention, compounds in which R1, R2, and R3 are hydrogen atoms and R4 is a methyl group, and compounds in which R1, R3 are hydrogen atoms, R2 is a phenyl group, and R4 is hydrogen Compounds other than those that are atoms or methoxy groups are new.
本発明の製造方法の酸化反応に用いられる酸化剤として
、金属過酸化物あるいは過硫酸などをあげることができ
る。金属過酸化物は金属酸化物の塩と過酸化物とによっ
て反応系内で生じさせて用いるが、このような塩として
、タングステン酸、モリブデン酸、バナジウム酸などの
塩をあげることができ、過酸化物として過酸化水素水を
あげることができる。これらの金属酸化物と過酸化物の
組み合わせの中でタングステン酸ナトリウムと過酸化水
素水の組み合わせが最も好ましい。Examples of the oxidizing agent used in the oxidation reaction of the production method of the present invention include metal peroxides and persulfuric acid. Metal peroxides are produced in a reaction system using metal oxide salts and peroxides, and examples of such salts include salts of tungstic acid, molybdic acid, and vanadate. Hydrogen peroxide can be cited as an oxide. Among these combinations of metal oxide and peroxide, the combination of sodium tungstate and hydrogen peroxide is the most preferred.
また、酸化剤は前記−数式(n)の化合物に対して0.
05〜1.0モルの金属酸化物および1〜10倍モルの
過酸化水素水の組み合わせで用いるが、金属酸化物0.
2モル、過酸化水素水10倍モルの比率が最も好ましい
。Further, the oxidizing agent is 0.0% with respect to the compound of formula (n) above.
It is used in combination of 0.05 to 1.0 moles of metal oxide and 1 to 10 times the mole of hydrogen peroxide, but 0.0 to 1.0 moles of metal oxide is used.
The most preferred ratio is 2 moles and 10 times the mole of hydrogen peroxide solution.
本発明の製造方法の酸化過程で生成する前記−数式(I
)の化合物でR4が水素原子である化合物は一般に不安
定で分解しやすいため、反応系内で適当なアルキル化剤
を反応させてアルキル化した後単離、精製した方が好ま
しいが、比較的安定な化合物、例えばR2がフェニル基
である化合物などの場合、アルキル化することなく単離
、精製することができる。The formula (I) produced in the oxidation process of the production method of the present invention
) compounds in which R4 is a hydrogen atom are generally unstable and easily decomposed. In the case of a stable compound, such as a compound in which R2 is a phenyl group, it can be isolated and purified without alkylation.
このようなアルキル化において使用することができるア
ルキル化剤としては、ジアゾメタンのほか例えば、メチ
ルヨーシト、アリルプロミドなど通常のアルキル化反応
に使用されるハロゲン化アルキル、ハロゲン化アルケニ
ルなどのアルキル化剤をあげることができる。In addition to diazomethane, examples of alkylating agents that can be used in such alkylation include alkylating agents such as alkyl halides and alkenyl halides used in ordinary alkylation reactions, such as methyl iosito and allyl bromide. I can do it.
本発明の製造方法を好適に実施するには、前記−数式(
II)の化合物を不活性有機溶媒、例えばメタノールに
溶解し、水冷撹拌下、これに酸化・剤、例えば0.2倍
モルのタングステン酸す)IJウム・二水和物の水溶液
および10倍モルの30%過酸化水素水のメタノール溶
液を加えて10〜20t’で約30分撹拌する。次いで
、必要に応じこれにアルキル化剤、例えばジアゾメタン
のエーテル溶液を加えてアルキル化した後、常法に従っ
て処理、精製することにより一般式(1)の化合物を得
る。In order to suitably carry out the manufacturing method of the present invention, the above-mentioned formula (
The compound of II) is dissolved in an inert organic solvent, such as methanol, and under water-cooled stirring, an oxidizing agent such as 0.2 times the mole of tungstic acid, an aqueous solution of IJum dihydrate, and a 10 times mole of tungstic acid are added thereto. Add a methanol solution of 30% hydrogen peroxide and stir at 10 to 20 t' for about 30 minutes. Then, if necessary, an alkylating agent such as an ether solution of diazomethane is added thereto for alkylation, followed by treatment and purification according to conventional methods to obtain the compound of general formula (1).
本発明の製造方法で得られる前記−数式(1)の化合物
は医薬品、動物用薬品、農業用薬品あるいはそれらの製
造中間体として有用な化合物である。The compound represented by formula (1) obtained by the production method of the present invention is a compound useful as a pharmaceutical, an animal drug, an agricultural drug, or a production intermediate thereof.
発明の効果
本発明の製造方法は、医薬品等あるいはその製造中間体
として有用な前記−数式(I)で表されるインドール誘
導体を簡便に効率よく製造することができる。Effects of the Invention The production method of the present invention can easily and efficiently produce the indole derivative represented by formula (I) above, which is useful as a pharmaceutical product or an intermediate for its production.
実施例
本発明の内容を以下の実施例によりさらに詳細に説明す
る。なお、各実施例中の化合物の融点はすべて未補正で
ある。EXAMPLES The content of the present invention will be explained in more detail with reference to the following examples. Note that all melting points of compounds in each example are uncorrected.
実施例 1
1−メトキシインドール
2.3−ジヒドロインドール47.5+ngをメタノー
ル4.0mlに溶解した溶液に水冷撹拌下にタングステ
ン酸ナトリウム・二水和物13.2mg (0、l m
ol eq、)を水0.5mNに溶かして加え、さらに
30%過酸化水素水452.5mg(10mol eq
、)をメタ/ /L/ 1 mj2 L溶かして加え
た。水浴をとり室温下(20℃)で30分間撹拌後、ジ
アゾメタンのエーテル溶液を発泡が認められなくなるま
で加えた。水を反応混合物に加え、塩化メチレンで抽出
した。抽出液を飽和食塩水で洗い、無水硫酸ナトリウム
で乾燥後、減圧下に溶媒を留去した。得られた残留物を
塩化メチレンを展開溶媒とするシリカゲル分取薄層クロ
マトグラフィーで精製して、1−メトキシインドール2
9.6mg (50%)を得た。Example 1 13.2 mg of sodium tungstate dihydrate (0, l m
ol eq,) dissolved in 0.5 mN of water and added thereto, and then 452.5 mg of 30% hydrogen peroxide solution (10 mol eq.
, ) was dissolved and added to the mixture in an amount of meta/ /L/ 1 mj2 L. After removing the water bath and stirring at room temperature (20° C.) for 30 minutes, an ether solution of diazomethane was added until no bubbling was observed. Water was added to the reaction mixture and extracted with methylene chloride. The extract was washed with saturated brine, dried over anhydrous sodium sulfate, and then the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel preparative thin layer chromatography using methylene chloride as a developing solvent to obtain 1-methoxyindole 2.
9.6 mg (50%) was obtained.
得られた1−メトキシインドールの物理化学的恒数は標
品のデータ(RoM、 Acheson et al、
J。The physicochemical constants of the obtained 1-methoxyindole are based on the standard data (RoM, Acheson et al.
J.
Chem、Soc、、 Perkin I、 197
8.1117) と一致した。Chem, Soc, Perkin I, 197
8.1117).
実施例 2
1−メトキシインドール
2.3−ジヒドロインドール42.2mgをアセトン−
水(10:l、 v/v)混合溶媒11.0−に溶解し
た液に過硫酸(2KH3O,、に1(SO4・に2SO
4) 239.8 mg (1,1mat eq、)を
加え、室温下(19℃)10分間撹拌した。Example 2 42.2 mg of 1-methoxyindole 2,3-dihydroindole was dissolved in acetone-
Persulfuric acid (2KH3O, 1 (SO4, 2SO
4) 239.8 mg (1.1 mat eq.) was added and stirred at room temperature (19°C) for 10 minutes.
反応液にジアゾメタンのエーテル溶液を発泡が認められ
なくなるまで加えた。水を反応混合物に加え、塩化メチ
レンで抽出した。抽出液を飽和食塩水で洗い、無水硫酸
す) IJウムで乾燥後、減圧下に溶媒を留去した。得
られた残留物を塩化メチジ; ンを展開溶媒とするシリ
カゲル分取薄層クロマトグラフィーで精製して、1−メ
トキシインドール6.0mg (11%)を得た。An ether solution of diazomethane was added to the reaction solution until no foaming was observed. Water was added to the reaction mixture and extracted with methylene chloride. The extract was washed with saturated brine, dried over anhydrous sulfuric acid, and then the solvent was distilled off under reduced pressure. The obtained residue was purified by preparative thin layer chromatography on silica gel using methylene chloride as a developing solvent to obtain 6.0 mg (11%) of 1-methoxyindole.
得られた1−メトキシインドールの物理化学的恒数は標
品のものと一致した。The physicochemical constants of the obtained 1-methoxyindole were consistent with those of the standard product.
実施例 3
1−メトキシ−5−二トロインドール
2.3−ジヒドロ−5−二トロインドール44.8mg
をメタノール3mAに溶解した溶液に室温下(17℃)
でタングステ酸ナトリウム・二水和物9.Qmg(0,
1mol eq、) を水0.3rR1に溶かして加え
、さらに30%過酸化水素水309.7mg(10mo
l eq、)をメタノール1−に溶かして加えた。室温
下(17℃)で7時間撹拌後、ジアゾメタンのエーテル
溶液を発泡が認められなくなるまで加えた。その後実施
例1と同じ後処理をし、得られた残留物を塩化メチレン
−〇−ヘキサン(7:3. v/v)混合溶媒を展開溶
媒とするシリカゲル分取薄層クロマトグラフィーで分離
、精製して、1−メトキシ−6−二トロインドール31
.3巾g(60%)を得た。Example 3 1-methoxy-5-nitroindole 2.3-dihydro-5-nitroindole 44.8 mg
was dissolved in 3 mA of methanol at room temperature (17°C).
Sodium tungstate dihydrate 9. Qmg(0,
Dissolve 1 mol eq.
l eq,) was dissolved in methanol 1- and added. After stirring at room temperature (17°C) for 7 hours, an ether solution of diazomethane was added until no bubbling was observed. Thereafter, the same post-treatment as in Example 1 was carried out, and the obtained residue was separated and purified by preparative thin layer chromatography on silica gel using a mixed solvent of methylene chloride-〇-hexane (7:3.v/v) as a developing solvent. and 1-methoxy-6-nitroindole 31
.. 3 g (60%) was obtained.
黄色針状晶 (メタノール)
融 点 = 90〜91℃
IR(にBr): 1613.1584.150B、
1358.1339゜756、72Q c+++−’
’H−NMR(CDC13)
δ: 4.17(311,s)、 6.45(18,d
d、 J=3.4 andl、0Hz)、 7.52(
1)1. d、 J=3.4)lz)、 7.60(1
)1. d、 J=8.8Hz)、 7.98(IH,
dd、 J=8.8and 2.2Hz)、8.38
(LH,brd、J=2.2Hz)MS m/z:
192(M”)
元素分析値: (CsHaN203として)0%
N% N%
計算値 56.25 4.20 14.58実
測値 56.21 4.17 14.73実施
例 4
1−メトキシ−5−ニトロインドール
2.3−ジヒドロ−5−二トロインドール40.8mg
、タングステン酸ナトリウム・二水和物16.4 mg
(0,2111016Q、)、30%過酸化水素水2
82.0mg (10moleq、 )、水0.5−お
よびメタノール5m12を用いて実施例1と同様に反応
し、後処理をした。得られた残留物を塩化メチレンを展
開溶媒とするシリカゲル分取薄層クロマトグラフィーで
分離、精製して、1−メトキシ−5−二トロインドール
23.2mg (49%)を得た。Yellow needle crystals (methanol) Melting point = 90-91℃ IR (Br): 1613.1584.150B,
1358.1339°756,72Q c+++-'' H-NMR (CDC13) δ: 4.17 (311, s), 6.45 (18, d
d, J=3.4 andl, 0Hz), 7.52(
1)1. d, J=3.4)lz), 7.60(1
)1. d, J=8.8Hz), 7.98(IH,
dd, J=8.8and 2.2Hz), 8.38
(LH,brd,J=2.2Hz)MS m/z:
192 (M”) Elemental analysis value: (as CsHaN203) 0%
N% N% Calculated value 56.25 4.20 14.58 Actual value 56.21 4.17 14.73 Example 4 1-methoxy-5-nitroindole 2.3-dihydro-5-nitroindole 40. 8mg
, sodium tungstate dihydrate 16.4 mg
(0,2111016Q,), 30% hydrogen peroxide solution 2
A reaction was carried out in the same manner as in Example 1 using 82.0 mg (10 moleq, ), 0.5 m of water and 5 ml of methanol, followed by post-treatment. The obtained residue was separated and purified by preparative thin layer chromatography on silica gel using methylene chloride as a developing solvent to obtain 23.2 mg (49%) of 1-methoxy-5-nitroindole.
淡黄色板状晶 (メタノール)
融 点: 89.5〜90.5℃IR(KBr)
: 1615. 15g0. 1512. 1324
. 1066.737 cm−1
’H−NMR(C口C1,)
δ: 4.14(3H,s)、 6.54(IH,
dd、 J=3.6 ando、8Hz)、 7.
38(IH,d、 J=3.6)1z)、 7.4
4(IH,d、 J=9.0Hz)、−8,12(L
H,dd、 J=9.0and 2.1Hz)、
8.54(IH,d、 J=2.lHz)MS m/
z: 192(Ma
元素分析値’ (CsHaN203として)0%
8% N%
計算値 56.25 4.20 14.58実
測値 56.25 4.17 14.50実施
例 5
7−ヨード−1−メトキシインドール
2.3−ジヒドロ−7−ヨードインドール218.7m
gをメタノール5tnlに溶解した溶液に、水冷撹拌下
タングステン酸ナトリウム・二水和物14.7@g (
0,05mol eq、)を加え、さらに30%過酸化
水素水303.6rBg (3mol eq、)をメタ
ノール4dに溶かして加えた。水浴をとり、24℃で5
時間撹拌後、ジアゾメタンのエーテル溶液を発泡が認め
られなくなるまで加えた。その後実施例1と同じ後処理
をし、得られた残留物を、塩化メチレン−n−ヘキサン
(1;5、 v/v)混合溶媒を溶出溶媒および展開溶
媒とするシリカゲルカラムクロマトグラフィーおよびシ
リカゲル分取薄層クロマトグラフィーで分離および精製
して、7−ヨード−1−メトキシインドール62.6m
g (26%)を得た。Pale yellow plate crystals (methanol) Melting point: 89.5-90.5°C IR (KBr)
: 1615. 15g0. 1512. 1324
.. 1066.737 cm-1'H-NMR (C port C1,) δ: 4.14 (3H, s), 6.54 (IH,
dd, J=3.6 ando, 8Hz), 7.
38 (IH, d, J=3.6)1z), 7.4
4 (IH, d, J=9.0Hz), -8,12 (L
H, dd, J=9.0and 2.1Hz),
8.54 (IH, d, J=2.1Hz) MS m/
z: 192 (Ma elemental analysis value' (as CsHaN203) 0%
8% N% Calculated value 56.25 4.20 14.58 Actual value 56.25 4.17 14.50 Example 5 7-iodo-1-methoxyindole 2.3-dihydro-7-iodoindole 218.7m
Sodium tungstate dihydrate 14.7@g (
0.05 mol eq.) was added, and 303.6 rBg (3 mol eq.) of 30% hydrogen peroxide solution dissolved in 4 d of methanol was further added. Take a water bath and store at 24℃ for 5 minutes.
After stirring for an hour, an ethereal solution of diazomethane was added until no bubbling was observed. Thereafter, the same post-treatment as in Example 1 was carried out, and the obtained residue was subjected to silica gel column chromatography and silica gel fractionation using a methylene chloride-n-hexane (1:5, v/v) mixed solvent as the eluent and developing solvent. Separation and purification by thin layer chromatography yielded 62.6 m of 7-iodo-1-methoxyindole.
g (26%) was obtained.
無色板状晶 (n−ヘキサン)
融 点:35〜35.5℃
IR(KBr): 1544.1333.1276、1
033.948゜775 cm−’
’tl−NMR(C[1C13)
δ: 4.0B(3H,s)、 6.31(IH,d、
J=3.4)1z)。Colorless plate crystals (n-hexane) Melting point: 35-35.5°C IR (KBr): 1544.1333.1276, 1
033.948°775 cm-''tl-NMR (C[1C13) δ: 4.0B (3H, s), 6.31 (IH, d,
J=3.4)1z).
6.82(1M、 t、 J=7.6)1z)、 7.
29(IH,d、 J=3.4Hz)、 7.54(I
L da、 J=7.6 and 1)Iz)。6.82 (1M, t, J=7.6)1z), 7.
29 (IH, d, J=3.4Hz), 7.54 (I
L da, J = 7.6 and 1) Iz).
7.68(E、 dd、 J=7.6 and 1)l
z)uS m/z;273(M”)
元素分析値: (CsHstNo として)0%
8% N%
計算値 39.59 2.95 5.12実
測値 39.53 2.99 5.13実施
例 6
■−メトキシインドールー2−カルボン酸メチルエステ
ル
2.3−ジヒドロインドール−2−カルボン酸51.5
mg。7.68(E, dd, J=7.6 and 1)l
z) uS m/z; 273 (M”) Elemental analysis value: (as CsHstNo) 0%
8% N% Calculated value 39.59 2.95 5.12 Actual value 39.53 2.99 5.13 Example 6 ■-Methoxyindole-2-carboxylic acid methyl ester 2.3-dihydroindole-2-carvone Acid 51.5
mg.
タングステン酸ナトリウム・二水和物20.8ng(0
,2mol eq、)、30%過酸化水素水358.2
mg (10mol eq、)、水0.5−およびメタ
ノール5mlを用い、実施例1と同様の反応を室温下(
16℃)で15分間行った。ジアゾメタンとの反応およ
び後処理を実施例1と同様に行い得られた残留物を塩化
メチレンを展開溶媒とするシリカゲル分取薄層クロマト
グラフィーで分離精製して、1−メトキシインドール−
2−カルボン酸エステル11.4mg (18%)を得
た。Sodium tungstate dihydrate 20.8ng (0
, 2 mol eq, ), 30% hydrogen peroxide solution 358.2
mg (10 mol eq.), water 0.5 and methanol 5 ml, the same reaction as in Example 1 was carried out at room temperature (
16° C.) for 15 minutes. The reaction with diazomethane and post-treatment were carried out in the same manner as in Example 1, and the resulting residue was separated and purified by preparative thin layer chromatography on silica gel using methylene chloride as a developing solvent to obtain 1-methoxyindole-
11.4 mg (18%) of 2-carboxylic acid ester was obtained.
無色板状晶 (メタノール)
融 点7 40.5〜41.5℃
IR(KBr): 1723.1239.1209.1
085.738 cm−’’H−NMR(CDCl2)
δ: 3.93(3H,s)、 4.19(3H,
s)、 7.08(IH。Colorless plate crystals (methanol) Melting point 7 40.5-41.5℃ IR (KBr): 1723.1239.1209.1
085.738 cm-''H-NMR (CDCl2) δ: 3.93 (3H, s), 4.19 (3H,
s), 7.08 (IH.
d、 J=1.2)1z) 、 7.02〜7.5
4 (311,m)。d, J=1.2)1z), 7.02~7.5
4 (311, m).
7.61(IH,dt、J=7.9 and 1.
0Hz)MS m/z: 205(Ma
元素分析値” (C++HzN(h として)0%
8% N%
計算値 64,38 5,40 6.83実
測値 64.19 5.45 −7.00実施例
7
9−メトキシ−1,2,3,4−テトラヒドロカルバシ
ー1、2.3.4.4a、 9a−ヘキサヒドロカルバ
ゾール50.6mg、タングステン酸ナトリウム・二水
和物19.3mg(0,2mol eQ、)、30%過
酸化水素水331.6mg(10mol eq;)、水
0.5mlよびメタノール5−を用いて、実施例1と同
様の反応を行い、同様の後処理をした。得られた残留物
を塩化メチレン−〇−へキサン<773. v/v)の
混合溶媒を展開溶媒とするシリカゲル分取薄層クロマト
グラフィーで精製して、9−メトキシ−1,2,3,4
−テトラヒドロカルバゾール32.2mg (55%)
を得た。7.61 (IH, dt, J=7.9 and 1.
0Hz) MS m/z: 205 (Ma elemental analysis value) (C++HzN (as h)) 0%
8% N% Calculated value 64,38 5,40 6.83 Actual value 64.19 5.45 -7.00 Example 7 9-methoxy-1,2,3,4-tetrahydrocarbathy 1,2.3 .4.4a, 9a-hexahydrocarbazole 50.6 mg, sodium tungstate dihydrate 19.3 mg (0.2 mol eQ,), 30% hydrogen peroxide solution 331.6 mg (10 mol eq;), water 0 The same reaction as in Example 1 was carried out using 5ml of methanol and 5ml of methanol, and the same post-treatment was carried out. The resulting residue was diluted with methylene chloride-〇-hexane <773. 9-methoxy-1,2,3,4 was purified by preparative thin layer chromatography on silica gel using a mixed solvent of
-tetrahydrocarbazole 32.2 mg (55%)
I got it.
無色オイル
IR(film): 2942.2842.1459.
1443.1230゜1046、735 cm−
’H−NMR(CDCI3)
δ: 1.68〜2.08(4H,m)、 2.52〜
2.92(41゜brm)、 3.99(3H,s)、
6.88〜7.48(411゜m)
MS m/z: 201(M”)
旧gh MS : m/z (C+sll+sN口とし
て)計算値 201.1152
実測値 201.1[34
実施例 8
9−メトキシカルバゾール
9−メトキシ−1,2,3,4−テトラヒドロカルバゾ
ール188.9mgをベンゼン30mj2に溶解した溶
液に2.3−ジクロロ−5,6−ジシアノ−1,4−ベ
ンゾキノン(00口)469.4 mg (2,2mo
l eq、)を加え、室温下(14℃)で3時間撹拌し
た。不溶沈澱をシリカの薄層を通して除去した。シリカ
の薄層を塩化メチレンで洗浄し、ろ液と洗液を合せ、減
圧下に溶媒を留去した。得られた残留物をn−ヘキサン
−酢酸エチルエステル(9:1. v/v)混合溶媒を
溶出溶媒とするシリカゲルカラムクロマトグラフィーで
精製して、9−メトキシカルバゾール121.1mg
(65%)を得た。Colorless oil IR (film): 2942.2842.1459.
1443.1230°1046,735 cm-'H-NMR (CDCI3) δ: 1.68-2.08 (4H, m), 2.52-
2.92 (41°brm), 3.99 (3H,s),
6.88-7.48 (411゜m) MS m/z: 201 (M") Old gh MS: m/z (as C+sll+sN mouth) Calculated value 201.1152 Actual value 201.1 [34 Example 8 9 -Methoxycarbazole 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (00 units) 469 to a solution of 188.9 mg of 9-methoxy-1,2,3,4-tetrahydrocarbazole dissolved in 30 mj2 of benzene .4 mg (2,2mo
l eq, ) was added thereto, and the mixture was stirred at room temperature (14°C) for 3 hours. The undissolved precipitate was removed through a thin layer of silica. The thin layer of silica was washed with methylene chloride, the filtrate and washings were combined, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography using n-hexane-ethyl acetate (9:1. v/v) mixed solvent as an eluent to obtain 121.1 mg of 9-methoxycarbazole.
(65%).
無色針状晶 (メタノール)
融 点 : 40〜41t
IR(KBr): 1601.1450.1320.1
233.1052゜946 c+c’
’H−NMR(CDCIり
δ: 4.12(3H,s)、 7.19(01,dd
、 J=7.3 and2.7Hz)、 7.25(L
H,dd、 J=7.3 and2.7Hz)、 7.
34〜7.58(411,m)、 8.02(2H。Colorless needle crystals (methanol) Melting point: 40-41t IR (KBr): 1601.1450.1320.1
233.1052゜946 c+c''H-NMR (CDCI δ: 4.12 (3H, s), 7.19 (01, dd
, J=7.3 and2.7Hz), 7.25(L
H, dd, J=7.3 and2.7Hz), 7.
34-7.58 (411, m), 8.02 (2H.
dt、 J=7.3 and 1.0Hz)MS m/
z: 197(M”)
元素分析値’ (C+J++NOとして)6%
8% N%
計算値 79.1? 5.62 7.10
実測値 79.36 5.55 7.21実
施例 9
1−ヒドロキシ−2−フェニルインドール2.3−ジヒ
ドロ−2−フェニルインドール51.5mgをメタノー
ル4.0−に溶解した溶液に水冷撹拌下タングステン酸
ナトリウム・三水和物17.4 mg (0,2mol
eq、)を水0.5屁に溶かして加え、さらに30%
過酸化水素水299.4mg(10mol eq、)を
メタノールldに溶かして加えた。水浴をとり、室温下
(20℃)で30分巻撹拌後、水を反応混合物に加え、
塩化メチレンで抽出した。抽出液を飽和食塩水で洗い、
無水硫酸す)IJウムで乾燥後、減圧下に溶媒を留去し
た。得られた残留物を塩化メチレン−メタノール(98
:2. v/v)混合溶媒を展開溶媒とするシリカゲル
分取薄層クロマトグラフィーで精製して、1−ヒドロキ
シ−2−フェニルインドール30.9@g(56%)を
得た。dt, J=7.3 and 1.0Hz) MS m/
z: 197 (M”) Elemental analysis value (as C+J++NO) 6%
8% N% Calculated value 79.1? 5.62 7.10
Actual value 79.36 5.55 7.21 Example 9 Tungsten was added to a solution of 51.5 mg of 1-hydroxy-2-phenylindole 2.3-dihydro-2-phenylindole dissolved in 4.0-methanol under water cooling and stirring. Sodium acid trihydrate 17.4 mg (0.2 mol
Dissolve eq,) in 0.5 fart of water, add and add 30%
299.4 mg (10 mol eq) of hydrogen peroxide solution was dissolved in methanol ld and added. After taking a water bath and stirring at room temperature (20°C) for 30 minutes, water was added to the reaction mixture.
Extracted with methylene chloride. Wash the extract with saturated saline,
After drying over anhydrous sulfuric acid (IJ), the solvent was distilled off under reduced pressure. The obtained residue was diluted with methylene chloride-methanol (98%
:2. The residue was purified by preparative thin layer chromatography on silica gel using a mixed solvent (v/v) as a developing solvent to obtain 30.9@g (56%) of 1-hydroxy-2-phenylindole.
淡黄色針状晶 (クロロホルム)
融 点 : 174 〜175 ℃ (dec
、)(lit” 、 mp 175℃)
IR(KBr): 2400.1625.1370.7
56.740゜683 cnr’
III−NMR(10%CD30D In CDCI3
)δ: 6.52(0,2H,s、 3位プロトン、
0.88分り化されている)、 6.88〜7.62
(711,m) 。Pale yellow needle crystals (chloroform) Melting point: 174-175℃ (dec
) (lit", mp 175℃) IR (KBr): 2400.1625.1370.7
56.740°683 cnr' III-NMR (10% CD30D In CDCI3
) δ: 6.52 (0,2H,s, 3rd position proton,
0.88), 6.88-7.62
(711, m).
7、68〜7.92 (2H,m)
MS m/z: 209(M+)
本 B、 Fischer、 Chem、
Ber、、 29. 2062 (189
6)。7, 68-7.92 (2H, m) MS m/z: 209 (M+) Book B, Fischer, Chem,
Ber,, 29. 2062 (189
6).
J、)11M、 H目1. D、P、G11vert、
and^、Fe1dsoff、 J、Org、Che
m9.40.3735(1975)
実施例 10
1−メトキシ−2−フェニルインドールニーヒドロキシ
−2−フェニルインドール30.9mgをメタノール3
.Omlに溶解した溶液に、ジアゾメタンのエーテル溶
液を発泡が認められなくなるまで加え、さらに少過剰を
加えて室温下(14℃)で12時間撹拌した。減圧下に
溶媒を留去して得られた粗結晶をn−ヘキサン−酢酸エ
チルエステル(4:l。J,) 11M, H eyes 1. D, P, G11vert,
and^, Fe1dsoff, J, Org, Che
m9.40.3735 (1975) Example 10 30.9 mg of 1-methoxy-2-phenylindole-nihydroxy-2-phenylindole was dissolved in methanol 3
.. An ether solution of diazomethane was added to the solution dissolved in Oml until no bubbling was observed, and a slight excess was added, followed by stirring at room temperature (14° C.) for 12 hours. The crude crystals obtained by distilling off the solvent under reduced pressure were mixed with n-hexane-ethyl acetate (4:l).
Vハ)を展開溶媒とするシリカゲル分取薄層クロマトグ
ラフィーを行い28.3mg (86%)の1−メトキ
シ−2−フェニルインドールを得た。Silica gel preparative thin layer chromatography using Vc) as a developing solvent was performed to obtain 28.3 mg (86%) of 1-methoxy-2-phenylindole.
淡黄色板状晶 (メタノール)
融 点 = 47〜48℃
(1it0. mp 49〜51 t’)IR(にO
r): 1597.956.760.741 cm−’
’)l−NMR(CDCI、)
δ: 3.73(31(、s)、 6.56(ill、
s)、 7.00〜7.66(7N、 m)、 7.
73〜7.91(2tl、 m)元素分析値’ (C
+sH+JOとして)0% 8% N%
計算′値 80.69 5.87 6
.27実測値 80.77 5,91 6.
04本 N、 Sugiyama、 M、
Akutagawa、 T、 Ga5ha
、 Y。Pale yellow plate crystals (methanol) Melting point = 47~48℃ (1it0.mp 49~51t') IR (niO
r): 1597.956.760.741 cm-'
') l-NMR (CDCI, ) δ: 3.73 (31 (, s), 6.56 (ill,
s), 7.00-7.66 (7N, m), 7.
73-7.91 (2tl, m) Elemental analysis value' (C
+sH+JO) 0% 8% N% Calculated value 80.69 5.87 6
.. 27 Actual value 80.77 5,91 6.
04 pieces N, Sugiyama, M,
Akutagawa, T., Ga5ha
, Y.
Saiga、 and H,Yamamoto、 Bu
ll、Chem、 Sac。Saiga, and H. Yamamoto, Bu.
ll, Chem, Sac.
Japan、 40.347 (1967)実施例 1
1
1−メトキシ−2−フェニルインドール2.3−ジヒド
ロ−2−フェニルインドール52.3mg。Japan, 40.347 (1967) Example 1
1 1-methoxy-2-phenylindole 2.3-dihydro-2-phenylindole 52.3 mg.
タングステン酸ナトリウム・二水和物17.7mg(0
,2mol eq、)、3Q%過酸化水素水304.1
mg(10mol eq、)、水0.5dおよびメタノ
ール5mlを用いて、実施例1と同様の反応を行い、同
様の後処理をした。得られた残留物をn−ヘキサン−酢
酸エチルエステル(5:1. v/v)混合溶媒を展開
溶媒とするシリカゲル分取薄層クロマトグラフィーで分
離精製して、1−メトキシ−2−フェニルインドール4
0.0mg (67%)を得た。Sodium tungstate dihydrate 17.7 mg (0
, 2 mol eq, ), 3Q% hydrogen peroxide solution 304.1
The same reaction as in Example 1 was carried out using 0.5 d of water and 5 ml of methanol, and the same post-treatment was carried out. The obtained residue was separated and purified by silica gel preparative thin layer chromatography using n-hexane-ethyl acetate (5:1. v/v) mixed solvent as a developing solvent to obtain 1-methoxy-2-phenylindole. 4
0.0 mg (67%) was obtained.
ここで得られた1−メトキシ−2−フェニルインドール
は実施例10で得られた化合物とすべてのデータが一致
した。All data of the 1-methoxy-2-phenylindole obtained here coincided with the compound obtained in Example 10.
Claims (4)
ルキル基、カルボキシル基、低級アルコキシカルボニル
基またはフェニル基であるか、あるいはR^1とR^2
が互いに結合して−(CH_2)_4−または−CH=
CH−CH=CH−基を形成するものであり、R^3は
水素原子、ハロゲン原子またはニトロ基である)で表さ
れる2,3−ジヒドロインドール誘導体を酸化した後、
必要に応じてアルキル化することを特徴とする、一般式 ▲数式、化学式、表等があります▼ (式中のR^1、R^2およびR^3は前記と同じ意味
をもち、R^4は水素原子、低級アルキル基または低級
アルケニル基である)で表されるインドール誘導体の製
造方法。(1) General formula ▲ Numerical formula, chemical formula, table, etc. ▼ (In the formula, R^1 is a hydrogen atom, R^2 is a hydrogen atom, a lower alkyl group, a carboxyl group, a lower alkoxycarbonyl group, or a phenyl group. , or R^1 and R^2
are combined with each other to form -(CH_2)_4- or -CH=
After oxidizing the 2,3-dihydroindole derivative represented by CH-CH=CH-, where R^3 is a hydrogen atom, a halogen atom, or a nitro group,
There are general formulas▲mathematical formulas, chemical formulas, tables, etc.▼ that are characterized by alkylation if necessary▼ (R^1, R^2 and R^3 in the formula have the same meaning as above, R^ 4 is a hydrogen atom, a lower alkyl group, or a lower alkenyl group).
をもつ)で表される2,3−ジヒドロインドール誘導体
を酸化した後、アルキル化することを特徴とする、一般
式 ▲数式、化学式、表等があります▼ (式中のR^1、R^2およびR^3は前記と同じ意味
をもち、R^5は低級アルキル基または低級アルケニル
基である)で表されるインドール誘導体の製造方法。(2) A 2,3-dihydroindole derivative represented by the general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (R^1, R^2 and R^3 in the formula have the same meanings as above) There are general formulas ▲ mathematical formulas, chemical formulas, tables, etc. that are characterized by alkylation after oxidation ▼ (R^1, R^2 and R^3 in the formula have the same meanings as above, and R^ 5 is a lower alkyl group or a lower alkenyl group).
化水素水を用いて酸化することを特徴とする請求項第1
項または第2項記載の製造方法。(3) Claim 1, characterized in that the oxidation is carried out using sodium tungstate dihydrate and hydrogen peroxide solution.
The manufacturing method according to item 1 or 2.
とする請求項第2項記載の製造方法。(4) The production method according to claim 2, wherein the alkylation is carried out using diazomethane.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16576489A JPH0331257A (en) | 1989-06-28 | 1989-06-28 | Production of indole derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16576489A JPH0331257A (en) | 1989-06-28 | 1989-06-28 | Production of indole derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0331257A true JPH0331257A (en) | 1991-02-12 |
Family
ID=15818599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16576489A Pending JPH0331257A (en) | 1989-06-28 | 1989-06-28 | Production of indole derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0331257A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002048107A1 (en) * | 2000-12-13 | 2002-06-20 | Pharma Mar, S.A. | Antitumoral carbazoles |
| JP2008537544A (en) * | 2005-03-17 | 2008-09-18 | プレジデント・アンド・フエローズ・オブ・ハーバード・カレツジ | Synthesis of abrinviramide, stephacidin B and their analogs |
| JP2013510106A (en) * | 2009-11-09 | 2013-03-21 | ウニヴェルシタ ディ ピサ | Lactate dehydrogenase (LDH) inhibitory compounds and pharmaceutical compositions containing these compounds |
-
1989
- 1989-06-28 JP JP16576489A patent/JPH0331257A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002048107A1 (en) * | 2000-12-13 | 2002-06-20 | Pharma Mar, S.A. | Antitumoral carbazoles |
| US7135494B2 (en) | 2000-12-13 | 2006-11-14 | Pharma Mar, S.A. | Antitumoral carbazoles |
| JP2008537544A (en) * | 2005-03-17 | 2008-09-18 | プレジデント・アンド・フエローズ・オブ・ハーバード・カレツジ | Synthesis of abrinviramide, stephacidin B and their analogs |
| JP2013510106A (en) * | 2009-11-09 | 2013-03-21 | ウニヴェルシタ ディ ピサ | Lactate dehydrogenase (LDH) inhibitory compounds and pharmaceutical compositions containing these compounds |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2119914C1 (en) | Derivatives of carbazolone and method of their synthesis | |
| EP0002978B1 (en) | Thiazolidinedione-2,4 derivatives, their preparation and pharmaceutical applications | |
| EP1118610A1 (en) | Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
| JPH07179389A (en) | 5,8-dichloro-1,4,9,10-anthracentetrone | |
| FR2468370A1 (en) | NEW PYRIDOTHIENOTRIAZINES AND PROCESS FOR PREPARING THEM | |
| EP1023898B1 (en) | Cyano-indoles as serotonine reuptake inhibitors and as 5-HT2c receptor ligands | |
| CA2213054C (en) | Novel bis(imido) derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| JP2868024B2 (en) | Improved process for producing ketone compounds | |
| WO1994020466A1 (en) | Novel 2-phenoxy ethylamine derivatives, their preparation and their therapeutical use | |
| JPH06199857A (en) | 5-deazaflave-6,9-quinone derivative and its production | |
| JPH0522712B2 (en) | ||
| KR100216422B1 (en) | Novel preperation method of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazole-4-one | |
| EP0412014A1 (en) | Benzothiazine derivatives, their preparation and their uses as medicines or as intermediates for the synthesis of medicines | |
| EP0099822B1 (en) | 1-(2-carbalkoxy-4-(thienylalkylamido)phenoxy)-3-amino-2-propanols, their preparation and their uses in therapy | |
| CA2227513C (en) | New ellipticine derivatives, their preparation process and the pharmaceutical compositions containing them | |
| JP3953225B2 (en) | Method for producing quinoline derivative | |
| JPH07247263A (en) | Production of methylthiobenzene compound | |
| JPH06228103A (en) | New octahydroacridine derivative and its production | |
| JP2893906B2 (en) | Method for producing unsaturated ketone compound | |
| FR2642068A1 (en) | NOVEL BENZOPYRAN DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| JPS63301885A (en) | Production of spirooxazine compound | |
| JPS6263564A (en) | Indole derivative | |
| JPH0477469A (en) | 4-nitroindole derivative | |
| JPH0399079A (en) | Indolizine derivative | |
| JPH0399081A (en) | Thienoindolizine derivative |